Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colocated Multidisciplinary Clinic Is Associated With Improved Timeliness to Postoperative Adjuvant Therapy in Head and Neck Cancer Patients.

Head & neck·2026
Same author

Survival and response outcomes in patients with recurrent/metastatic head and neck cancer treated with opioids and statins: an exploratory pilot study.

Translational cancer research·2026
Same author

Integrating systemic therapy into larynx preservation: Lessons from 3 decades of progress.

Cancer·2026
Same author

Minimizing Chemoradiation Using a Surgical Algorithm for HPV-Associated Cancer of Unknown Primary.

Head & neck·2025
Same author

Does Water Irrigation Control Pleomorphic Adenoma Cell Growth Better Than Saline?

OTO open·2025
Same author

Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study.

Laryngoscope investigative otolaryngology·2025

Related Experiment Video

Updated: Jan 14, 2026

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

10.2K

A Practical Method for Detecting Prognostic CD57+ T Cells in Head and Neck Cancer.

Brianna Brammer1,2, Brendan L C Kinney1,2, Vikash Kansal1,2

  • 1Department of Otolaryngology-Head and Neck Surgery, Emory University, Atlanta, Georgia, USA.

Head & Neck
|October 17, 2025
PubMed
Summary

Predicting head and neck squamous cell carcinoma (HNSCC) recurrence is crucial. Elevated highly differentiated, CD57+ effector memory T (HD TEMRA) cells can predict recurrence, aiding personalized treatment planning.

Keywords:
CD57TEMRA cellsbiomarkerflow cytometryhead and neck cancerrecurrence

More Related Videos

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

8.9K
Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
10:58

Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry

Published on: March 5, 2019

14.5K

Related Experiment Videos

Last Updated: Jan 14, 2026

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

10.2K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

8.9K
Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
10:58

Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry

Published on: March 5, 2019

14.5K

Area of Science:

  • Immunology
  • Oncology
  • Flow Cytometry

Background:

  • Head and neck squamous cell carcinoma (HNSCC) recurrence impacts survival in nearly half of patients.
  • Current methods lack robust prediction of HNSCC recurrence.
  • Elevated circulating highly differentiated, CD57+ effector memory T (HD TEMRA) cells correlate with early recurrence and poor outcomes in HNSCC.

Purpose of the Study:

  • To present refined flow cytometry panels for predicting HNSCC recurrence.
  • To simplify the identification of HD TEMRA cells as a prognostic biomarker.

Main Methods:

  • Utilized refined, less complex flow cytometry panels.
  • Identified HD TEMRA cells as live CD8+ CD28- CD57+ cells.
  • Analyzed a cohort of surgically treated HNSCC patients.

Main Results:

  • Refined flow cytometry panels effectively predicted HNSCC recurrence.
  • The proportion of HD TEMRA cells (CD8+ CD57+) predicted locoregional recurrence in oral squamous cell carcinoma patients.
  • Simplified panels retained prognostic value.

Conclusions:

  • Refined panels enhance the clinical utility of HD TEMRA cell proportion as a biomarker.
  • Simplified identification of HD TEMRA cells improves technical and analytic ease.
  • Implementing HD TEMRA cell proportion can personalize HNSCC treatment strategies.